Literature DB >> 9212234

Functional role of alpha4beta1 and alpha5beta1 integrin fibronectin receptors expressed on adriamycin-resistant MCF-7 human mammary carcinoma cells.

A Nista1, C Leonetti, G Bernardini, M Mattioni, A Santoni.   

Abstract

Cytofluorimetric and reverse-transcription polymerase chain reaction (RT-PCR) analysis showed that adriamycin-resistant (ADRR), but not sensitive (WT), MCF-7 human mammary carcinoma cell lines express alpha4beta1 and alpha5beta1 integrins. ADR(R) cells adhere to fibronectin (FN), and only alpha5beta1 is involved in cell adhesion to this glycoprotein, while alpha4beta1 mediates cell binding to the cellular counter-receptor VCAM-1. Proliferation assays showed that FN, but not VCAM-1, delivers a mitogenic signal to quiescent ADR(R) MCF-7 cells. The activating signal is mediated by alpha5beta1, since cell proliferation is inhibited in the presence of RGD peptide or specific antibody. Cell cycle analysis demonstrated that cell/FN interaction induces the re-entry of ADR(R) MCF-7 into S phase, and prevents them from undergoing serum deprivation-induced apoptosis. Our data suggest that the presence of alpha5beta1 on the resistant cells enables them to draw advantage from FN for both cell growth and survival.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9212234     DOI: 10.1002/(sici)1097-0215(19970703)72:1<133::aid-ijc19>3.0.co;2-k

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines.

Authors:  J S Damiano; A E Cress; L A Hazlehurst; A A Shtil; W S Dalton
Journal:  Blood       Date:  1999-03-01       Impact factor: 22.113

2.  beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium.

Authors:  Valerie M Weaver; Sophie Lelièvre; Johnathon N Lakins; Micah A Chrenek; Jonathan C R Jones; Filippo Giancotti; Zena Werb; Mina J Bissell
Journal:  Cancer Cell       Date:  2002-09       Impact factor: 31.743

3.  Regulation of keratin and integrin gene expression in cancer and drug resistance.

Authors:  N Daly; P Meleady; D Walsh; M Clynes
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

4.  Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin alpha5beta1 and fibronectin.

Authors:  Jin-Min Nam; Yasuhito Onodera; Mina J Bissell; Catherine C Park
Journal:  Cancer Res       Date:  2010-06-01       Impact factor: 12.701

5.  Structural Biology of the Tumor Microenvironment.

Authors:  Joseph W Freeman
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Tissue factor-expressing tumor cells can bind to immobilized recombinant tissue factor pathway inhibitor under static and shear conditions in vitro.

Authors:  Sara P Y Che; Christine DeLeonardis; Michael L Shuler; Tracy Stokol
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

7.  Cytokeratin 8 ectoplasmic domain binds urokinase-type plasminogen activator to breast tumor cells and modulates their adhesion, growth and invasiveness.

Authors:  Natasa Obermajer; Bojan Doljak; Janko Kos
Journal:  Mol Cancer       Date:  2009-10-21       Impact factor: 27.401

8.  Autocrine laminin-5 ligates alpha6beta4 integrin and activates RAC and NFkappaB to mediate anchorage-independent survival of mammary tumors.

Authors:  Nastaran Zahir; Johnathon N Lakins; Alan Russell; WenYu Ming; Chandrima Chatterjee; Gabriela I Rozenberg; M Peter Marinkovich; Valerie M Weaver
Journal:  J Cell Biol       Date:  2003-12-22       Impact factor: 10.539

9.  Progression of luminal breast tumors is promoted by ménage à trois between the inflammatory cytokine TNFα and the hormonal and growth-supporting arms of the tumor microenvironment.

Authors:  Polina Weitzenfeld; Nurit Meron; Tal Leibovich-Rivkin; Tsipi Meshel; Adit Ben-Baruch
Journal:  Mediators Inflamm       Date:  2013-12-04       Impact factor: 4.711

10.  Coadministration of the FNIII14 Peptide Synergistically Augments the Anti-Cancer Activity of Chemotherapeutic Drugs by Activating Pro-Apoptotic Bim.

Authors:  Takuya Iyoda; Yumi Nagamine; Yoshitomi Nakane; Yuya Tokita; Shougo Akari; Kazuki Otsuka; Motomichi Fujita; Keisuke Itagaki; You-Ichi Takizawa; Hiroaki Orita; Toshiyuki Owaki; Jyunichi Taira; Ryo Hayashi; Hiroaki Kodama; Fumio Fukai
Journal:  PLoS One       Date:  2016-09-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.